Who owns ARS Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SPRY from SEC Form 13F filings across 208 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 208 institutions disclosed 90.6M shares of ARS Pharmaceuticals, Inc. worth $726.0M — about 91.2% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
208
13F holders
$726.0M
value, 2026 filers
91.2%
of shares outstanding (90.6M sh)
40
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of SPRY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 10.9M | $87.0M | 0.8% | 10.9% | 0.0% |
| 2 | Rubric Capital Management LP | 8.5M | $68.4M | 0.6% | 8.6% | +6.8% |
| 3 | ORBIMED ADVISORS LLC | 8.3M | $66.4M | 1.2% | 8.3% | 0.0% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 7.5M | $60.1M | 0.6% | 7.6% | 0.0% |
| 5 | BlackRock, Inc. | 5.3M | $42.5M | 0.0% | 5.3% | +6.0% |
| 6 | Tyro Capital Management LLC | 4.5M | $35.7M | 8.0% | 4.5% | +50.2% |
| 7 | Aberdeen Group plc | 4.2M | $33.4M | 0.0% | 4.2% | +1.4% |
| 8 | SR One Capital Management, LP | 4.0M | $32.1M | 3.1% | 4% | 0.0% |
| 9 | STATE STREET CORP | 3.7M | $29.9M | 0.0% | 3.8% | +2.4% |
| 10 | Capital World InvestorsNEW | 2.8M | $22.1M | 0.0% | 2.8% | new |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $20.5M | 0.0% | 2.6% | +0.4% |
| 12 | MILLENNIUM MANAGEMENT LLC | 2.4M | $19.2M | 0.0% | 2.4% | -59.9% |
| 13 | Janney Montgomery Scott LLC | 2.1M | $16.5M | 0.0% | 2.1% | +2.4% |
| 14 | UBS Group AG | 1.9M | $15.5M | 0.0% | 2% | -14.2% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $13.6M | 0.0% | 1.7% | +11.3% |
| 16 | BOOTHBAY FUND MANAGEMENT, LLC | 1.6M | $12.8M | 0.2% | 1.6% | +539.1% |
| 17 | GENERAL AMERICAN INVESTORS CO INC | 1.1M | $9.1M | 0.5% | 1.1% | +55.8% |
| 18 | Third Point LLC | 1.0M | $8.0M | 0.2% | 1% | 0.0% |
| 19 | PEREGRINE CAPITAL MANAGEMENT LLCNEW | 672,139 | $5.4M | 0.2% | 0.7% | new |
| 20 | Tejara Capital Ltd | 607,039 | $4.9M | 2.0% | 0.6% | +188.5% |
| 21 | ADAR1 Capital Management, LLC | 600,999 | $4.8M | 0.2% | 0.6% | -55.9% |
| 22 | Pavaki Capital Management LLCNEW | 579,600 | $4.6M | 1.6% | 0.6% | new |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 566,829 | $4.5M | 0.0% | 0.6% | +11.0% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551,416 | $4.4M | 0.0% | 0.6% | +3.4% |
| 25 | NORTHERN TRUST CORP | 549,064 | $4.4M | 0.0% | 0.6% | +3.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.